Subcutaneous Nivolumab for RCC: CheckMate 67T Practice-Changing Results
51:09
Immunotherapy-based combinations for advanced/metastatic renal cell carcinoma: ASCO GU 2023
6:12
CheckMate 67T: Logistical Benefits, Considerations of Subcutaneous Nivolumab for RCC
16:47
Jimmy Kimmel Reacts to Donald Trump’s Inauguration
26:55
What is Lumbar Stenosis? Symptoms, Causes & Benefits of Ultrasonic Technology
17:18
Boost Your Bone Density with These 6 Life-Changing Tips
58:10
"Metastatic Renal Cell Cancer-An embarrassment of riches,how do we choose" by Prateek Mendiratta, MD
54:16
Rethinking Breast Cancer: Optimal Trial Design and Exploring Novel Modalities
2:38:21